The effective date for the telehealth rules “Expansion of Buprenorphine Treatment via Telemedicine Encounter” and “Continuity of Care via Telemedicine for Veterans Affairs Patients” has been delayed to December 31, 2025. The first rule amends related regulations to expand the… Read More ›
The U.S. Drug Enforcement Agency (DEA) has recently extended COVID-19 Public Health Emergency (COVID-19 PHE) telemedicine flexibilities with regards to the prescribing of controlled substances until December 31, 2024, as it continues its rulemaking with regards to whether the requirement… Read More ›
Through proposed amendments to its Health Breach Notification Rule (16 CFR Part 318), the FTC is currently seeking to formalize the extension of notification requirements as to covered security breaches of consumers’ electronic health information to developers of health applications… Read More ›